← back to search

Jörg Hofmann

Charité - Universitätsmedizin Berlin · DE
Area of research
Infectious Diseases · Hepatology
Research interest
Research interests include Viral Infections and Vectors, Viral Infections and Outbreaks Research, Viral gastroenteritis research and epidemiology, and Hepatitis Viruses Studies and Epidemiology.
h-index
45
citations
10,342
works
228
NIH funding
primary concept
Medicine
email

Recent publications

Hantavirus-Infektionen
DGPI Handbuch 2026cited by 0position: contributordoi
Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation
Nature 2025cited by 8position: middledoi
Confusing variety of symptoms: Lyme carditis coinciding with Puumala hantavirus infection
Diagnostic Microbiology and Infectious Disease 2025cited by 1position: lastdoi
Confusing variety of symptoms: Lyme carditis coinciding with Puumala hantavirus infection
Diagnostic Microbiology and Infectious Disease 2025cited by 1position: contributordoi
Revision of the “Guideline of the German Medical Association on Quality Assurance in Medical Laboratory Examinations – Rili-BAEK”
Journal of Laboratory Medicine 2024cited by 17position: middledoi
Fatal Disseminated Hepatitis E in an Adult Patient with IKBKB GOF Mutation.
2024cited by 3position: contributordoi
Refugees from Ukraine: children and adolescents with HIV in Germany
The Lancet HIV 2023cited by 7position: middledoi
Molecular characterisation of a rabbit Hepatitis E Virus strain detected in a chronically HEV-infected individual from Germany
One Health 2023cited by 6position: lastdoi
Insertions and deletions in the hypervariable region of the hepatitis E virus genome in individuals with acute and chronic infection
Liver International 2023cited by 5position: middledoi
Refugees from Ukraine: children and adolescents with HIV in Germany.
2023cited by 5position: contributordoi
Molecular characterisation of a rabbit Hepatitis E Virus strain detected in a chronically HEV-infected individual from Germany.
2023cited by 4position: contributordoi
Insertions and deletions in the hypervariable region of the hepatitis E virus genome in individuals with acute and chronic infection.
2023cited by 4position: contributordoi
Risk Factors for Hepatitis E Virus Infection and Eating Habits in Kidney Transplant Recipients.
2023cited by 3position: contributordoi
Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients
Journal of Clinical Medicine 2022cited by 85position: middledoi
Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients.
2022cited by 73position: contributordoi
Real-life experiences with bulevirtide for the treatment of hepatitis delta-48 weeks data from a German centre.
2022cited by 19position: contributordoi
Advanced sequencing approaches detected insertions of viral and human origin in the viral genome of chronic hepatitis E virus patients
Scientific Reports 2022cited by 17position: middledoi
Autochthonous West Nile virus infection in Germany: Increasing numbers and a rare encephalitis case in a kidney transplant recipient.
2022cited by 17position: contributordoi
Advanced sequencing approaches detected insertions of viral and human origin in the viral genome of chronic hepatitis E virus patients.
2022cited by 16position: contributordoi
Case Report: Rubella Virus-Induced Cutaneous Granulomas in Two Pediatric Patients With DNA Double Strand Breakage Repair Disorders – Outcome After Hematopoietic Stem Cell Transplantation
Frontiers in Immunology 2022cited by 11position: middledoi
Predictors of Serological Response to SARS-CoV-2 Vaccination in Kidney Transplant Patients: Baseline Characteristics, Immunosuppression, and the Role of IMPDH Monitoring
Journal of Clinical Medicine 2022cited by 10position: middledoi
Case Report: Rubella Virus-Induced Cutaneous Granulomas in Two Pediatric Patients With DNA Double Strand Breakage Repair Disorders - Outcome After Hematopoietic Stem Cell Transplantation.
2022cited by 7position: contributordoi
Predictors of Serological Response to SARS-CoV-2 Vaccination in Kidney Transplant Patients: Baseline Characteristics, Immunosuppression, and the Role of IMPDH Monitoring.
2022cited by 7position: contributordoi
Cluster of human<i>Puumala orthohantavirus</i>infections due to indoor exposure?—An interdisciplinary outbreak investigation
Zoonoses and Public Health 2022cited by 5position: middledoi
[Hantavirus Disease: An Update].
2022cited by 5position: contributordoi
Single Oral Doses of MK-8507, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor, Suppress HIV-1 RNA for a Week.
2022cited by 5position: contributordoi
SARS-CoV-2 screening in patients in need of urgent inpatient treatment in the Emergency Department (ED) by digitally integrated point-of-care PCR: a clinical cohort study.
2022cited by 5position: contributordoi
Cluster of human Puumala orthohantavirus infections due to indoor exposure?-An interdisciplinary outbreak investigation.
2022cited by 4position: contributordoi
Frequent intrathecal production of antibodies to the viral capsid antigen of Epstein-Barr virus in patients with central nervous system post-transplant lymphoproliferative disorder.
2022cited by 2position: contributordoi
Declining Course of Humoral Immune Response in Initially Responding Kidney Transplant Recipients after Repeated SARS-CoV-2 Vaccination.
2022cited by 1position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Claus‐Thomas Bock · Robert Koch Institute9 papers (2019–2023)Victor M. Corman · University of Edinburgh8 papers (2021–2024)Mira Choi · Yonsei University6 papers (2020–2023)C.–Thomas Bock · Medizinische Hochschule Hannover6 papers (2018–2023)Joachim Seybold · Humboldt-Universität zu Berlin5 papers (2021–2021) · 5 papers (2021–2026)Christian Drosten · University of Edinburgh5 papers (2020–2021) · 5 papers (2018–2023)Robert Öllinger · Freie Universität Berlin4 papers (2020–2021)Victor M. Corman · Humboldt-Universität zu Berlin4 papers (2020–2022)Jürgen J. Wenzel · Institute of Medical Microbiology and Hygiene4 papers (2020–2021) · 3 papers (2022–2023)Terry C. Jones · Corvid Technologies (United States)3 papers (2021–2021)Eva Schrezenmeier · Leibniz Association3 papers (2020–2022)Daniel Tödt · Bochum University of Applied Sciences3 papers (2020–2023) · 3 papers (2022–2023)Klemens Budde · Humboldt-Universität zu Berlin3 papers (2020–2022)Kai‐Uwe Eckardt · Friedrich-Alexander-Universität Erlangen-Nürnberg3 papers (2021–2022)Heiner Wedemeyer · Ruhr University Bochum3 papers (2020–2021)Fabian Halleck · Humboldt-Universität zu Berlin3 papers (2020–2022)